Compared with adalimumab, several biologic medications had superior safety profiles for the treatment of moderate to severe psoriasis.

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), cardiovascular events (11.2%), and pulmonary complications (8.4%). Common ...

Platelet-rich plasma combined with fractional laser therapy was a safe and effective treatment option for adults with vitiligo.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in high-impact areas.